ELLIPTA: Clinical Trials

6 completed. 6 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	6	Completed 6

Follow ELLIPTA: new trials by email Literature Review of ELLIPTA trials Research Report on ELLIPTA

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD) FF/UMEC/VI, ELLIPTA - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	229	2023-06-06	2025-03-24
A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma ELLIPTA, BREEZHALER - Asthma	Phase 4	Completed	GlaxoSmithKline	114	2021-04-14	2023-05-15
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	732	2018-06-25	2020-10-28
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	729	2018-06-25	2020-10-28
To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma ELLIPTA, DISKUS/ACCUHALER, MDI - Asthma	Phase 4	Completed	GlaxoSmithKline	162	2014-11-01	2015-11-23
Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices ELLIPTA, DISKUS/ACCUHALER, MDI - Pulmonary Disease, Chronic Obstructive	Phase 4	Completed	GlaxoSmithKline	569	2014-08-28	2017-05-23

Conditions studied

Pulmonary Disease, Chronic Obstructive (4)  ·  Asthma (2)

Sponsors

GlaxoSmithKline (6)

Countries

Netherlands (4)  ·  Czechia (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  United States (2)  ·  India (1)

Results publications

PMID 27883002, PMID 36368290

NIH funding

2017 (2)